Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Dinney

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
The Urologic Clinics of North America|March 4, 2000
The potential role of gene therapy in the treatment of bladder cancerJ T Hsieh, C P Dinney, L W Chung
The Journal of Urology|January 1, 1996
Therapy of locally recurrent renal cell carcinoma after nephrectomyS Tanguay, L L Pisters, D D Lawrence, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362T Utsugi, C P Dinney, J J Killion, et al.
The Journal of Urology|March 21, 1998
Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinomaD A Levy, J W Slaton, D A Swanson, et al.
The Journal of Urology|August 24, 1999
A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladderJ W Slaton, D A Swanson, H B Grossman, et al.
Urology|May 1, 1993
Diagnostic testing for prostate cancer detection: less is bestR J Babaian, C P Dinney, E I Ramirez, et al.
The Journal of Urology|April 1, 1993
Lymphoepithelioma of the bladder: a clinicopathological study of 3 casesC P Dinney, J Y Ro, R J Babaian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and scheduleJ W Slaton, P Perrotte, K Inoue, et al.
Lymphokine and Cytokine Research|December 1, 1991
In situ activation of mouse lung macrophages by coadministration of liposomes containing the lipopeptide CGP 31362 and interleukin 2 involves interaction with T lymphocytes and natural killer cellsT Utsugi, C P Dinney, J J Killion, et al.
Cancer|December 11, 1999
Rationale for bladder-sparing surgery in patients with locally advanced colorectal carcinomaM D Balbay, J W Slaton, N Trane, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
The Urologic Clinics of North America|March 4, 2000
The potential role of gene therapy in the treatment of bladder cancerJ T Hsieh, C P Dinney, L W Chung
The Journal of Urology|January 1, 1996
Therapy of locally recurrent renal cell carcinoma after nephrectomyS Tanguay, L L Pisters, D D Lawrence, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362T Utsugi, C P Dinney, J J Killion, et al.
The Journal of Urology|March 21, 1998
Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinomaD A Levy, J W Slaton, D A Swanson, et al.
The Journal of Urology|August 24, 1999
A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladderJ W Slaton, D A Swanson, H B Grossman, et al.
Urology|May 1, 1993
Diagnostic testing for prostate cancer detection: less is bestR J Babaian, C P Dinney, E I Ramirez, et al.
The Journal of Urology|April 1, 1993
Lymphoepithelioma of the bladder: a clinicopathological study of 3 casesC P Dinney, J Y Ro, R J Babaian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and scheduleJ W Slaton, P Perrotte, K Inoue, et al.
Lymphokine and Cytokine Research|December 1, 1991
In situ activation of mouse lung macrophages by coadministration of liposomes containing the lipopeptide CGP 31362 and interleukin 2 involves interaction with T lymphocytes and natural killer cellsT Utsugi, C P Dinney, J J Killion, et al.
Cancer|December 11, 1999
Rationale for bladder-sparing surgery in patients with locally advanced colorectal carcinomaM D Balbay, J W Slaton, N Trane, et al.
Pageof 8